Association of leukocyte DNA methylation changes with dietary folate and alcohol intake in the EPIC study.


Journal

Clinical epigenetics
ISSN: 1868-7083
Titre abrégé: Clin Epigenetics
Pays: Germany
ID NLM: 101516977

Informations de publication

Date de publication:
02 04 2019
Historique:
received: 12 11 2018
accepted: 20 02 2019
entrez: 4 4 2019
pubmed: 4 4 2019
medline: 22 1 2020
Statut: epublish

Résumé

There is increasing evidence that folate, an important component of one-carbon metabolism, modulates the epigenome. Alcohol, which can disrupt folate absorption, is also known to affect the epigenome. We investigated the association of dietary folate and alcohol intake on leukocyte DNA methylation levels in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Leukocyte genome-wide DNA methylation profiles on approximately 450,000 CpG sites were acquired with Illumina HumanMethylation 450K BeadChip measured among 450 women control participants of a case-control study on breast cancer nested within the EPIC cohort. After data preprocessing using surrogate variable analysis to reduce systematic variation, associations of DNA methylation with dietary folate and alcohol intake, assessed with dietary questionnaires, were investigated using CpG site-specific linear models. Specific regions of the methylome were explored using differentially methylated region (DMR) analysis and fused lasso (FL) regressions. The DMR analysis combined results from the feature-specific analysis for a specific chromosome and using distances between features as weights whereas FL regression combined two penalties to encourage sparsity of single features and the difference between two consecutive features. After correction for multiple testing, intake of dietary folate was not associated with methylation level at any DNA methylation site, while weak associations were observed between alcohol intake and methylation level at CpG sites cg03199996 and cg07382687, with q Alcohol intake was associated with methylation levels at two CpG sites. Evidence from DMR and FL analyses indicated that dietary folate and alcohol intake may be associated with genomic regions with tumor suppressor activity such as the GSDMD and HOXA5 genes. These results were in line with the hypothesis that epigenetic mechanisms play a role in the association between folate and alcohol, although further studies are warranted to clarify the importance of these mechanisms in cancer.

Sections du résumé

BACKGROUND
There is increasing evidence that folate, an important component of one-carbon metabolism, modulates the epigenome. Alcohol, which can disrupt folate absorption, is also known to affect the epigenome. We investigated the association of dietary folate and alcohol intake on leukocyte DNA methylation levels in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Leukocyte genome-wide DNA methylation profiles on approximately 450,000 CpG sites were acquired with Illumina HumanMethylation 450K BeadChip measured among 450 women control participants of a case-control study on breast cancer nested within the EPIC cohort. After data preprocessing using surrogate variable analysis to reduce systematic variation, associations of DNA methylation with dietary folate and alcohol intake, assessed with dietary questionnaires, were investigated using CpG site-specific linear models. Specific regions of the methylome were explored using differentially methylated region (DMR) analysis and fused lasso (FL) regressions. The DMR analysis combined results from the feature-specific analysis for a specific chromosome and using distances between features as weights whereas FL regression combined two penalties to encourage sparsity of single features and the difference between two consecutive features.
RESULTS
After correction for multiple testing, intake of dietary folate was not associated with methylation level at any DNA methylation site, while weak associations were observed between alcohol intake and methylation level at CpG sites cg03199996 and cg07382687, with q
CONCLUSIONS
Alcohol intake was associated with methylation levels at two CpG sites. Evidence from DMR and FL analyses indicated that dietary folate and alcohol intake may be associated with genomic regions with tumor suppressor activity such as the GSDMD and HOXA5 genes. These results were in line with the hypothesis that epigenetic mechanisms play a role in the association between folate and alcohol, although further studies are warranted to clarify the importance of these mechanisms in cancer.

Identifiants

pubmed: 30940212
doi: 10.1186/s13148-019-0637-x
pii: 10.1186/s13148-019-0637-x
pmc: PMC6444439
doi:

Substances chimiques

Folic Acid 935E97BOY8

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

57

Subventions

Organisme : Cancer Research UK
ID : C570/A16491
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M012190/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N003284/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0500300
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00011/5
Pays : United Kingdom
Organisme : Medical Research Council
ID : 1000143
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0401527
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C18281/A19169
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00011/1
Pays : United Kingdom
Organisme : World Health Organization
ID : 001
Pays : International
Organisme : Medical Research Council
ID : MC_UU_12013/2
Pays : United Kingdom
Organisme : Medical Research Council
ID : G1000143
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00011/4
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C8221/A19170
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 14136
Pays : United Kingdom

Références

Bioinformatics. 2013 Jan 15;29(2):189-96
pubmed: 23175756
Bioinformatics. 2012 Mar 15;28(6):882-3
pubmed: 22257669
Public Health Nutr. 2002 Dec;5(6B):1287-96
pubmed: 12639233
Hum Mol Genet. 1999 Apr;8(4):683-90
pubmed: 10072438
Genes Chromosomes Cancer. 2004 Jul;40(3):218-28
pubmed: 15139001
JAMA. 1999 May 5;281(17):1632-7
pubmed: 10235158
Proc Natl Acad Sci U S A. 2012 Jun 26;109(26):10522-7
pubmed: 22689993
Stat Appl Genet Mol Biol. 2004;3:Article3
pubmed: 16646809
Proc Natl Acad Sci U S A. 2008 Dec 2;105(48):18718-23
pubmed: 19033188
BMC Bioinformatics. 2012 May 08;13:86
pubmed: 22568884
Nat Rev Genet. 2018 Jun;19(6):371-384
pubmed: 29643443
Oncogene. 2016 Oct 20;35(42):5539-5551
pubmed: 27157614
Nat Commun. 2016 Feb 10;7:10577
pubmed: 26861414
Clin Epigenetics. 2018 Mar 21;10:38
pubmed: 29588806
World J Stem Cells. 2015 Apr 26;7(3):583-95
pubmed: 25914765
Nutr Res Rev. 2012 Jun;25(1):68-95
pubmed: 22853843
Epigenetics Chromatin. 2015 Jan 27;8:6
pubmed: 25972926
IARC Monogr Eval Carcinog Risks Hum. 2012;100(Pt E):1-538
pubmed: 23193840
Front Chem. 2014 Aug 11;2:61
pubmed: 25157349
Circ Cardiovasc Genet. 2016 Oct;9(5):436-447
pubmed: 27651444
Eur J Clin Nutr. 2007 Sep;61(9):1037-56
pubmed: 17375121
J Natl Cancer Inst. 2014 Dec 12;107(1):367
pubmed: 25505228
Epigenomics. 2016 May;8(5):599-618
pubmed: 26864933
Nat Rev Cancer. 2010 May;10(5):361-71
pubmed: 20357775
J Biol Chem. 2014 May 16;289(20):13810-20
pubmed: 24711445
Am J Dermatopathol. 2011 Apr;33(2):140-3
pubmed: 21399449
Alcohol. 2005 Apr;35(3):235-41
pubmed: 16054985
Oncogene. 2013 Aug 8;32(32):3754-64
pubmed: 22964635
Eur J Cancer. 2017 Apr;75:299-307
pubmed: 28259012
Genes Chromosomes Cancer. 2009 Mar;48(3):261-71
pubmed: 19051310
Int J Cancer. 2017 Mar 15;140(6):1246-1259
pubmed: 27905104
Int J Epidemiol. 2010 Apr;39(2):417-20
pubmed: 19926667
J Cancer Res Clin Oncol. 2005 Mar;131(3):157-62
pubmed: 15599595
Mol Nutr Food Res. 2011 Jan;55(1):166-80
pubmed: 21207520
Genomics. 2011 Oct;98(4):288-95
pubmed: 21839163
Adv Cancer Res. 1997;71:93-119
pubmed: 9111864
Public Health Nutr. 2002 Dec;5(6B):1113-24
pubmed: 12639222
Eur J Clin Nutr. 2011 Apr;65(4):480-5
pubmed: 21245875
BMC Bioinformatics. 2010 Nov 30;11:587
pubmed: 21118553
Public Health Nutr. 2003 Jun;6(4):407-13
pubmed: 12795830
J Neurochem. 2014 Jun;129(5):770-80
pubmed: 24521073
BMJ. 2005 Oct 8;331(7520):807
pubmed: 16087654
Biometrics. 1946 Dec;2(6):110-4
pubmed: 20287815
Clin Epigenetics. 2015 Nov 14;7:121
pubmed: 26568774
Nat Methods. 2015 Feb;12(2):115-21
pubmed: 25633503
PLoS Genet. 2007 Sep;3(9):1724-35
pubmed: 17907809
Public Health Nutr. 2002 Dec;5(6B):1125-45
pubmed: 12639223
Bioinformatics. 2008 Jul 1;24(13):1547-8
pubmed: 18467348
Nucleic Acids Res. 2016 Jan 4;44(D1):D733-45
pubmed: 26553804
Mol Psychiatry. 2018 Feb;23(2):422-433
pubmed: 27843151
Epigenetics. 2013 Feb;8(2):203-9
pubmed: 23314698
Toxicol Sci. 2011 Apr;120(2):235-55
pubmed: 21297083

Auteurs

F Perrier (F)

Nutritional Methodology and Biostatistics Group, International Agency for Research on Cancer (IARC), World Health Organization, 150, cours Albert Thomas, 69372, Lyon CEDEX 08, France.

V Viallon (V)

Nutritional Methodology and Biostatistics Group, International Agency for Research on Cancer (IARC), World Health Organization, 150, cours Albert Thomas, 69372, Lyon CEDEX 08, France.

S Ambatipudi (S)

Epigenetics Group, IARC, Lyon, France.
MRC Integrative Epidemiology Unit, Bristol Medical School, University of Bristol, Bristol, UK.

A Ghantous (A)

Epigenetics Group, IARC, Lyon, France.

C Cuenin (C)

Epigenetics Group, IARC, Lyon, France.

H Hernandez-Vargas (H)

Epigenetics Group, IARC, Lyon, France.

V Chajès (V)

Nutritional Epidemiology Group, IARC, Lyon, France.

L Baglietto (L)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

M Matejcic (M)

Nutritional Epidemiology Group, IARC, Lyon, France.
Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, CA, USA.

H Moreno-Macias (H)

Universidad Autonoma Metropolitana, Mexico City, Mexico.

T Kühn (T)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

H Boeing (H)

Department of Epidemiology, German Institute of Human Nutrition (DIfE), Potsdam-Rehbrücke, Germany.

A Karakatsani (A)

Hellenic Health Foundation, Athens, Greece.
2nd Pulmonary Medicine Department, School of Medicine, National and Kapodistrian University of Athens, "ATTIKON" University Hospital, Haidari, Greece.

A Kotanidou (A)

Hellenic Health Foundation, Athens, Greece.
1st Department of Critical Care Medicine and Pulmonary Services, University of Athens Medical School, Evangelismos Hospital, Athens, Greece.

A Trichopoulou (A)

Hellenic Health Foundation, Athens, Greece.

S Sieri (S)

Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

S Panico (S)

Dipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy.

F Fasanelli (F)

Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin, Via Santena 7, Turin, Italy.

M Dolle (M)

National Institute of Public Health and the Environment (RIVM), Centre for Health Protection (pb12), Bilthoven, The Netherlands.

C Onland-Moret (C)

Department of Epidemiology, Julius Center Research Program Cardiovascular Epidemiology, Utrecht, The Netherlands.

I Sluijs (I)

Department of Epidemiology, Julius Center Research Program Cardiovascular Epidemiology, Utrecht, The Netherlands.

E Weiderpass (E)

Department of Research, Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Genetic Epidemiology Group, Folkhälsan Research Center and Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Department of Community Medicine, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.

J R Quirós (JR)

Public Health Directorate, Asturias, Spain.

A Agudo (A)

Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.

J M Huerta (JM)

Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain.
CIBER Epidemiology and Public Health CIBERESP, Madrid, Spain.

E Ardanaz (E)

Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain.
CIBER Epidemiology and Public Health CIBERESP, Madrid, Spain.
Navarra Public Health Institute, Pamplona, Spain.
IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.

M Dorronsoro (M)

Public Health Direction and Biodonostia Research Institute and CIBERESP, Basque Regional Health Department, San Sebastian, Spain.

T Y N Tong (TYN)

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

K Tsilidis (K)

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.

E Riboli (E)

Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.

M J Gunter (MJ)

Nutritional Epidemiology Group, IARC, Lyon, France.

Z Herceg (Z)

Epigenetics Group, IARC, Lyon, France.

P Ferrari (P)

Nutritional Methodology and Biostatistics Group, International Agency for Research on Cancer (IARC), World Health Organization, 150, cours Albert Thomas, 69372, Lyon CEDEX 08, France. ferrarip@iarc.fr.

I Romieu (I)

Nutritional Epidemiology Group, IARC, Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH